Literature DB >> 8139392

Interaction of dietary fatty acids and cyclosporine A in the borderline hypertensive rat: tissue fatty acids.

D E Mills1, R de Antueno, J Scholey.   

Abstract

In this study we examined (i) the effects of cyclosporine A (CS) on tissue lipid composition and (ii) the effect of changes in dietary n-6 fatty acids on tissue responses to CS. Fatty acid composition of liver, kidney, heart and brain were determined after 4 wk of treatment with CS (10 mg/kg.d p.o.) in male borderline hypertensive rats (BHR, n = 4/group), whose diet was supplemented with either safflower oil or evening primrose oil (EPO). Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine/phosphatidylinositol, triglyceride and cholesteryl ester fatty acids were measured in kidney, heart, brain and liver. The same parameters were also measured in safflower-fed BHR (n = 4) receiving placebo. The effects of CS on liver microsomal delta 9, delta 6 and delta 5 desaturases in vitro were also followed. CS affected the fatty acid composition of all tissues examined, with the greatest changes seen in the renal phosphatidylcholine and phosphatidylserine/phosphatidylinositol fractions. All CS-induced changes that occurred in the liver, brain and renal fatty acids were reversed by EPO. CS elevated delta 9 desaturase but had no effect on delta 6 and delta 5 desaturase. In light of (i) the observation that EPO normalizes renal function and blood pressure in CS-treated BHR, and (ii) the importance of the kidney in blood pressure regulation, the data suggest that the beneficial effects of EPO on CS toxicity may involve changes in renal phospholipid fatty acid profiles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139392     DOI: 10.1007/bf02537087

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  38 in total

1.  Acute cyclosporine nephrotoxicity--prototype for a renal membrane signalling disorder.

Authors:  K L Skorecki; W P Rutledge; R W Schrier
Journal:  Kidney Int       Date:  1992-07       Impact factor: 10.612

2.  What is cyclosporine nephrotoxicity?

Authors:  B D Myers
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

3.  Dissociation between the immunosuppressive activity of cyclosporine derivatives and their effects on intracellular calcium signaling in mesangial cells.

Authors:  H J Goldberg; P Y Wong; E H Cole; G A Levy; K L Skorecki
Journal:  Transplantation       Date:  1989-04       Impact factor: 4.939

4.  Stimulation of intrinsic prostacyclin synthesis and inhibition of thromboxane production to minimize cyclosporine nephrotoxicity.

Authors:  S Teraoka; T Sanaka; K Takahashi; H Toma; Y Yamaguchi; T Yagisawa; K Tanabe; H Sato; O Matsumura; I Nakajima
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

5.  The prostaglandin E1 analog misoprostol reverses acute cyclosporine nephrotoxicity.

Authors:  M S Paller
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

Review 6.  Pathophysiology of cyclosporine nephrotoxicity: role of eicosanoids.

Authors:  W M Bennett; L Elzinga; V Kelley
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

7.  Systemic hypertension after cardiac transplantation: effect of cyclosporine on the renin-angiotensin-aldosterone system.

Authors:  M Bellet; C Cabrol; P Sassano; P Léger; P Corvol; J Ménard
Journal:  Am J Cardiol       Date:  1985-12-01       Impact factor: 2.778

8.  Fatty acid desaturase activities are modulated by phytosterol incorporation in microsomes.

Authors:  A I Leikin; R R Brenner
Journal:  Biochim Biophys Acta       Date:  1989-09-25

9.  Effects of dietary fish oil on renal insufficiency in rats with subtotal nephrectomy.

Authors:  L A Scharschmidt; N B Gibbons; L McGarry; P Berger; M Axelrod; R Janis; Y H Ko
Journal:  Kidney Int       Date:  1987-11       Impact factor: 10.612

10.  Effect of dietary alpha- and gamma-linolenic acid on tissue fatty acids in guinea pigs.

Authors:  Y S Huang; D F Horrobin; M S Manku; J Mitchell
Journal:  Proc Soc Exp Biol Med       Date:  1985-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.